BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27925274)

  • 1. Supplementation of a clinical trial by historical control data: is the prospect of dynamic borrowing an illusion?
    Galwey NW
    Stat Med; 2017 Mar; 36(6):899-916. PubMed ID: 27925274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian hypothesis testing with frequentist characteristics in clinical trials.
    Quan H; Zhang B; Lan Y; Luo X; Chen X
    Contemp Clin Trials; 2019 Dec; 87():105858. PubMed ID: 31669448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of historical control data for assessing treatment effects in clinical trials.
    Viele K; Berry S; Neuenschwander B; Amzal B; Chen F; Enas N; Hobbs B; Ibrahim JG; Kinnersley N; Lindborg S; Micallef S; Roychoudhury S; Thompson L
    Pharm Stat; 2014; 13(1):41-54. PubMed ID: 23913901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incorporating historical two-arm data in clinical trials with binary outcome: A practical approach.
    Feißt M; Krisam J; Kieser M
    Pharm Stat; 2020 Sep; 19(5):662-678. PubMed ID: 32227680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of Bayesian dynamic borrowing from an imperfectly commensurate historical control.
    Harun N; Liu C; Kim MO
    Pharm Stat; 2020 Sep; 19(5):613-625. PubMed ID: 32185886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A dynamic power prior for borrowing historical data in noninferiority trials with binary endpoint.
    Liu GF
    Pharm Stat; 2018 Feb; 17(1):61-73. PubMed ID: 29125220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one-arm and hybrid control two-arm trials.
    Kopp-Schneider A; Wiesenfarth M; Held L; Calderazzo S
    Pharm Stat; 2024; 23(1):4-19. PubMed ID: 37632266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covariate-adjusted borrowing of historical control data in randomized clinical trials.
    Han B; Zhan J; John Zhong Z; Liu D; Lindborg S
    Pharm Stat; 2017 Jul; 16(4):296-308. PubMed ID: 28560815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian Dynamic Borrowing of Historical Information with Applications to the Analysis of Large-Scale Assessments.
    Kaplan D; Chen J; Yavuz S; Lyu W
    Psychometrika; 2023 Mar; 88(1):1-30. PubMed ID: 35687222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using Bayesian statistics in confirmatory clinical trials in the regulatory setting: a tutorial review.
    Lee SY
    BMC Med Res Methodol; 2024 May; 24(1):110. PubMed ID: 38714936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive blinded sample size adjustment for comparing two normal means--a mostly Bayesian approach.
    Hartley AM
    Pharm Stat; 2012; 11(3):230-40. PubMed ID: 22422722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dynamic power prior approach to non-inferiority trials for normal means.
    Mariani F; De Santis F; Gubbiotti S
    Pharm Stat; 2024; 23(2):242-256. PubMed ID: 37964403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using historical control information for the design and analysis of clinical trials with overdispersed count data.
    Gsteiger S; Neuenschwander B; Mercier F; Schmidli H
    Stat Med; 2013 Sep; 32(21):3609-22. PubMed ID: 23722585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian semiparametric meta-analytic-predictive prior for historical control borrowing in clinical trials.
    Hupf B; Bunn V; Lin J; Dong C
    Stat Med; 2021 Jun; 40(14):3385-3399. PubMed ID: 33851441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel power prior approach for borrowing historical control data in clinical trials.
    Shi Y; Li W; Liu GF
    Stat Methods Med Res; 2023 Mar; 32(3):493-508. PubMed ID: 36601652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian clinical trial design using historical data that inform the treatment effect.
    Psioda MA; Ibrahim JG
    Biostatistics; 2019 Jul; 20(3):400-415. PubMed ID: 29547966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian sample size for exploratory clinical trials incorporating historical data.
    Whitehead J; Valdés-Márquez E; Johnson P; Graham G
    Stat Med; 2008 Jun; 27(13):2307-27. PubMed ID: 18069728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A practical Bayesian adaptive design incorporating data from historical controls.
    Psioda MA; Soukup M; Ibrahim JG
    Stat Med; 2018 Nov; 37(27):4054-4070. PubMed ID: 30033617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging data across studies using frequentist and Bayesian estimation.
    Zhang T; Lipkovich I; Marchenko O
    J Biopharm Stat; 2017; 27(3):426-441. PubMed ID: 28287342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scaled kernel density estimation prior for dynamic borrowing of historical information with application to clinical trial design.
    Warren JL; Wang Q; Ciarleglio MM
    Stat Med; 2024 Apr; 43(8):1615-1626. PubMed ID: 38345148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.